News

Archive: 07/07/2019

A gut feeling about success

An exciting development for research into gastrointestinal bacterial infections has been announced in New York, by US-based biopharmaceutical company, AzurRx BioPharma. The company has licensed MTAN Inhibitor technology developed through...